ArticleBMC plant biology2026
Leveraging probabilistic models to enhance soybean cultivar recommendation in Zimbabwe.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Harnessing high-throughput phenotyping and artificial intelligence for soybean breeding: From trait assessment to data-driven decisions.Plant phenomics (Washington, D.C.) · 2026Review
- Envirotyping-driven strategies to enhance soybean adaptation across Southern Africa.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cultivar recommendation is a critical stage in plant breeding programs, and selecting superior varieties for multiple traits remains a challenge due to the variety × environment (V×E) interaction. The Pan-African Trials Network aims to expand soybean cultivar recommendations across new tropical and subtropical regions. However, varieties exhibit distinct adaptation patterns across environments. Bayesian probabilistic models offer a way to manage cultivar recommendation risk through the V×E interaction. This study aimed to identify soybean varieties with high probabilities of superior performance across years and locations using a Bayesian Probabilistic Selection Index (BPSI) in a multi-trait and multi-environment framework. Ninety-seven soybean varieties were evaluated across 37 environments and six crop seasons in Zimbabwe using a randomized complete block design with three replications. Traits evaluated included grain yield, plant height, and lodging. The probability of superior performance was estimated using a 20% selection intensity for each trait and 10% for the multi-trait index. Plant height showed the highest experimental precision, whereas grain yield exhibited greater variability across environments. Most varieties performed better across groups of years than groups of locations, indicating stronger variety × location than variety × year interaction. The BPSI identified ten varieties with high probabilities of superior performance across environments in Zimbabwe. Selected varieties achieved probabilities above 60% for grain yield, 80% for plant height, and 50% for lodging, indicating greater yield stability and reduced selection risk. Pairwise comparisons confirmed that unselected varieties performed worse than selected ones. By integrating the probability of superior performance within and across environments, the BPSI effectively identified varieties with both specific and broad adaptation. This Bayesian framework provides a robust, data-driven approach for cultivar recommendation in Zimbabwe, combining predictive accuracy and risk management. The BPSI shows strong potential to enhance soybean breeding decisions under heterogeneous environmental conditions, and further studies should extend this approach to other crops, traits, with enviromic and genomic data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.